QHSLab, Inc.

USAQ

OTC

Healthcare

Medical - Devices

West Palm Beach, FL, US4 employeesusaqcorp.com

—

At a Glance

AI-generated

QHSLab, Inc.

Revenue breakdown: Integrated Service Program (36.6%), Allergy Diagnostic Kit Sales (34.3%), Immunotherapy Treatment Sales (18.6%).

8-K

QHSLab reported strong fiscal 2025 results with 26% revenue growth to $2.69 million, improved profitability, and significant balance sheet strengthening through debt restructuring.

—

Market Cap

—

Revenue

—

Net Income

Employees4

Fundamentals

How The Business Makes Money

Revenue by Segment

Integrated Service Program36.6%($2M)

Allergy Diagnostic Kit Sales34.3%($2M)

Immunotherapy Treatment Sales18.6%($897.1K)

Clinical Study Revenue5.5%($267.3K)

Subscription Revenue2%($98.3K)

Shipping And Handling1.6%($77.6K)

Training And Other Revenue1.3%($63.0K)

Activity

What Changed Recently

Regulation FD

Mar 30, 2026

and shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subjec

Regulation FD

Jan 25, 2026

and shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subjec

Material Agreement+3 More

Jan 22, 2026

Entry Into a Material Definitive Agreement. QHSLab, Inc. (the “Company”) consummated a Note Repurchase Agreement (the “Repurchase Agreement”) with MedScience Re

Regulation FD

Jan 15, 2026

and shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subjec

Regulation FD

Jan 5, 2026

and shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subjec

Peer Companies

Company	Price	Change	Market Cap	P/E
NUMDNu-Med Plus, Inc.	—	—	—	—
APLIFAppili Therapeutics Inc.	—	—	—	—
CVGRFCity View Green Holdings ...	—	—	—	—
AGNPFAlgernon Pharmaceuticals ...	—	—	—	—
GENPFGenix Pharmaceuticals Cor...	—	—	—	—
IBXXFImagion Biosystems Limite...	—	—	—	—
NMLSFRestart Life Sciences Cor...	—	—	—	—
MSIUMedical Supply Internatio...	—	—	—	—

Analyst View

Company Profile

CIK0000856984

ISINUS90350R1077

CUSIP90350R107

Phone929 379 6503

Address901 Northpoint Parkway, West Palm Beach, FL, 33407, US

SEC EDGAR